Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report) has been given a consensus rating of “Reduce” by the twelve brokerages that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $10.5909.
Several analysts recently weighed in on the company. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a “hold” rating on the stock. UBS Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th.
Check Out Our Latest Analysis on Walgreens Boots Alliance
Hedge Funds Weigh In On Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
WBA opened at $11.89 on Friday. The firm has a market cap of $10.29 billion, a P/E ratio of -1.63, a price-to-earnings-growth ratio of 1.40 and a beta of 0.80. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $13.25. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.32 and a current ratio of 0.60. The business’s fifty day moving average is $11.53 and its 200-day moving average is $11.11.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. Walgreens Boots Alliance’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.63 EPS. Sell-side analysts expect that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- How to Profit From Growth Investing
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
- Stock Splits, Do They Really Impact Investors?
- Amazon’s Bears Have Raised the White Flag—Get Excited
- What is a Low P/E Ratio and What Does it Tell Investors?
- Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.